Grantham, Mayo, Van Otterloo & Co (GMO)’s Zoetis ZTS Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio ZTS Stock Details ZTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$743K	Hold	10,345	–	–	﹤0.01%	544
2026 Q1	$1.22M	Buy	10,345 +1,200	+13%	+$148K	﹤0.01%	489
2025 Q4	$1.15M	Buy	9,145 +1,335	+17%	+$174K	﹤0.01%	497
2025 Q3	$1.14M	Buy	7,810 +1,010	+15%	+$153K	﹤0.01%	465
2025 Q2	$1.06M	Buy	6,800 +2,500	+58%	+$396K	﹤0.01%	473
2025 Q1	$708K	Buy	+4,300	New	+$715K	﹤0.01%	494

Other funds holding ZTS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s ZTS Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) held its Zoetis (ZTS) position steady in Q2 2026 at 10,345 shares worth $743K. The position accounts for ﹤0.01% of the portfolio, ranked #544.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ZTS in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.22M in Q1 2026. 1,429 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

Grantham, Mayo, Van Otterloo & Co (GMO) held 10,345 shares of Zoetis worth $743K as of Q2 2026.
Grantham, Mayo, Van Otterloo & Co (GMO) left its Zoetis share count unchanged in Q2 2026.
Zoetis made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #544 holding.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Zoetis in Q1 2025 and has held it in 6 quarters since.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Zoetis position peaked at $1.22M in Q1 2026.
1,429 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.